Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance enzastaurin after whole-brain radiotherapy for brain metastases from lung cancer
2006-000889-36Phase 2Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchial carcinoma comparing Enzastaurin plus best supportive care with Placebo plus best supportive care (2 arms). Primary endpoint: Time to progression of brain metastases. Started Jun 2006; status: terminated.
02
Drugs
enzastaurin
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on 2006-000889-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000889-36.